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Background: Epithelioid angiosarcoma is a rare variant of angiosarcoma, and is characterized by an epithelioid
morphologic appearance that mimics carcinoma. These tumors usually arise in extraskeletal sites; origination in
bone is rare.
Case presentation: A 69-year-old woman presented with right knee pain. Plain radiographs and magnetic resonance
imaging showed an osteolytic lesion with a large soft-tissue extension into the distal femur. Under a diagnosis of
metastatic carcinoma of unknown origin based on the biopsy specimen, resection and replacement with an artificial
joint were performed. Histologic analysis of the resected material confirmed epithelioid angiosarcoma, supported by
immunoexpression of cytokeratins and vascular markers. Three months after surgery, metastasis to the bone and lymph
nodes was observed, and the patient died of the disease shortly thereafter.
Discussion: Epithelioid angiosarcoma of bone is characterized by an aggressive clinical course. A possibility of
epithelioid angiosarcoma of bone should be considered in cases with such epithelial features, particularly if only small
specimens are available.
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Angiosarcoma is a malignant mesenchymal neoplasm in
which the tumor cells exhibit endothelial differentiation.
Angiosarcoma frequently develops in sun-exposed skin
of elderly individuals. It is characterized by aggressive
biological behavior, resulting in a high rate of local re-
currence, metastasis to lymph nodes, and systemic me-
tastasis [1,2].
Epithelioid angiosarcoma is a rare variant of angiosar-
coma that is characterized by large cells with epithelioid
features. It mimics poorly differentiated carcinoma
through its epithelial appearance. Epithelioid angiosar-
coma most often arises in the deep soft tissues of the ex-
tremities, although a variety of other primary sites,
including the thyroid gland, skin, and adrenal glands,
have also been reported [3,4]. However, bone is a very
rare origination site for this malignancy [5-7]. Herein,
we report a case with epithelioid angiosarcoma in the
bone characterized by an aggressive clinical course, in* Correspondence: akio@med.kyushu-u.ac.jp
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cinoma of unknown origin.Case presentation
A 69-year-old woman developed right knee pain 6 months
prior to initial evaluation at our institute. She had tender-
ness over the distal thigh region, and the pain worsened
on bearing weight. No laboratory data abnormalities were
detected, except for an increased white blood cell count
(15,000 white blood cells/μl) and elevation of the inflam-
matory marker C-reactive protein (5.27 mg/dl). Plain ra-
diographs showed an osteolytic lesion with undefined
margins and destroyed cortical bone in the distal femur.
Neither periosteal reaction nor calcification was observed
in the lesion (Figure 1A). Magnetic resonance imaging re-
vealed that the lesion measured 7 cm in longitudinal
diameter and was associated with a large soft-tissue mass
that extended in a posterior direction. The lesions dis-
played low signal intensity on T1-weighted images and
heterogeneous signal intensity on T2-weighted images.
Gadolinium enhancement was observed heterogeneouslyral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Epithelioid angiosarcoma images. (A) Plain X-radiographs show an osteolytic lesion in the distal femur. (B) This lesion has apparently
widened after 1 month. (C) Magnetic resonance imaging shows a lobulated lesion with a low signal on T1-weighted imaging (top) and a
heterogeneous signal on T2-weighted imaging (middle), and heterogeneous gadolinium enhancement is observed on T1-weighted imaging
(bottom). (D) [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography reveals a solitary lesion in the distal femur.
Figure 2 Epithelioid angiosarcoma histology. The tumor is
composed of large, epithelioid cells with vesicular nuclei and prominent
nucleoli (A), with fibrous stroma (B). (C) Vascular formation and
malignant endothelial cells containing erythrocytes are observed. (D)
Increased mitotic activity is observed. Immunohistochemically, tumor
cells express cytokeratins AE1/AE3 (E) and the vascular marker CD31 (F).
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eration the patient’s age, the clinical diagnoses were meta-
static carcinoma and primary malignant bone tumors
consisting of leiomyosarcoma of bone, osteosarcoma, and
undifferentiated high-grade pleomorphic sarcoma of bone.
A histological specimen on open biopsy suggested a
diagnosis of metastatic carcinoma, owing to the epithelial
morphology. To search for a primary carcinoma, com-
puted tomography from neck to pelvis, gastrointestinal
endoscopy, and colonoscopy were performed, but these
failed to detect a lesion. Multiple tumor markers, includ-
ing α-fetoprotein, carcinoembryonic antigen, CA125,
CA19-9, and squamous cell carcinoma antigen were ex-
amined and their levels were found to be normal. No
other lesions were identified by [18F]-2-fluoro-2-deoxy-D-
glucose positron emission tomography (FDG-PET), in
which the standardized uptake value was 12 (Figure 1D).
The diagnosis of a solitary metastasis of unknown origin
was made. Plain radiographs prior to resection, taken
1 month after the initial evaluation, showed that the area
of lysis had widened and the cortex surrounding the lesion
had disappeared (Figure 1B). Complete resection was per-
formed, although the margin to the proximal major nerve
and blood vessels was narrow. The bone was subsequently
replaced with an artificial joint.
Microscopically, the resected tumor cells appeared to
have epithelioid features, and vascular channels or
cystically dilated spaces were present. The tumor cells
had abundant eosinophilic cytoplasm and large nuclei
Figure 3 Postoperative epithelioid angiosarcoma images. (A)
Three months after tumor resection and artificial joint replacement,
plain radiographs show multiple osteolytic lesions at the femur and
the tibia (arrows). (B) [18F]-2-fluoro-2-deoxy-D-glucose positron
emission tomography shows multiple lesions extending from the
pelvic cavity to the lower extremity.
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cally, the tumor cells expressed cytokeratins AE1/AE3
(Figure 2E) and CAM 5.2, as well as the vascular marker
CD31 (Figure 2F). Expression of another vascular
marker, CD34, was not detected, and factor VIII ex-
pression was faint.
Three months after surgery, plain radiographs showed
multiple osteolytic lesions at the femur and tibia along
the artificial joint (Figure 3A), while FDG-PET showed
multiple metastases, distributed from the right pelvis to
the leg (Figure 3B). The patient died of the disease
shortly thereafter.Table 1 Clinical summary of reported ten cases with epithelio
Mean age (range) Sex (male/female) Solitary (4/10; 40%) Multi











The table is modified from Table one in reference [7].Discussion
Epithelioid angiosarcoma is a variant of angiosarcoma,
which is composed of neoplastic cells with an epithelioid
morphologic appearance. This type of tumor is character-
ized by poor differentiation and biological aggressiveness.
A previous series of ten cases of epithelioid angiosarcoma
of bone is summarized in Table 1. The series included
eight men and two women, who ranged in age from 26 to
83 years (mean, 62 years) [7]. The current patient is
69 years old, which is consistent with this age range. Of
the previous ten cases, four were solitary and six were
multifocal. Of the four solitary tumors, three were located
in the femur [7]. The initial tumor location in the current
case was also the femur; thus, the femur appears to be a
frequent site of solitary metastasis.
Metastatic carcinoma can be difficult to distinguish
from epithelioid angiosarcoma. Both tumors are com-
posed of epithelioid tumor cells, and they tend to affect
older individuals. In a previous report, 3 of 10 cases
were misdiagnosed as metastatic carcinoma [7]. Fur-
thermore, the cytokeratin expression characteristic of
epithelioid angiosarcoma may lead to a misdiagnosis of
metastatic carcinoma. Identifying histologic features of
epithelioid angiosarcomas, including the presence of
well-formed vascular channels and cytoplasmic vacu-
oles that contain red blood cell fragments, is essential.
However, the small amount of sample that can be ob-
tained with biopsy may also lead to an incorrect diagnosis
of metastatic carcinoma. Epithelioid hemangioendothe-
lioma is also a differential diagnosis of epithelioid
angiosarcoma, because both tumors share a number of
histopathologic features of epithelioid cells with intra-
cytoplasmic lumina. However, epithelioid hemangioen-
dothelioma is a low-grade malignant vascular tumor with
minimal cellular pleomorphism. Epithelioid hemangioen-
dothelioma is less aggressive than epithelioid angiosar-
coma [7,8].id angiosarcoma in the bone
focal (6/10; 60%) Metastasis 7/9 (78%) Died of disease 7/9 (78%)
ne case Time to death
r Lung 7 weeks to 27 months
Soft tissue
Bone
Time to death (<2 years)
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diagnosis of epithelioid angiosarcoma. Among vascular
markers, CD31 has been reported to be the most sensi-
tive [7]. However, it is important to be aware that ex-
pression of all vascular markers does not have to be
negative. In the current case, factor VIII was faintly
expressed, while CD34 expression was negative. In a pre-
vious report, factor VIII immunoexpression was positive
in 6 of 8 cases, and CD34 expression was detected in
only 2 of 5 cases [7].
Epithelioid angiosarcoma can metastasize to both
lymph nodes and organs, including the lungs, bone, soft
tissue, and skin, whereas most malignant soft-tissue tu-
mors only metastasize to the lungs. More than 50% of
patients with epithelioid angiosarcomas die from the dis-
ease within 2 to 3 years of diagnosis [2,3,7]. In the
current case, the tumor recurred 3 months after surgery,
and the patient died shortly thereafter, owing to quick
spread of the cancer. Bone metastasis was not only prox-
imal to, but also at a site from the original bone lesion.
FDG-PET was useful for detecting multiple metastases
to lymph nodes and bones.Conclusions
In summary, we have reported that epithelioid angiosar-
coma of the bone is characterized by an aggressive na-
ture. To differentiate it from a metastatic tumor, careful
histological examination using immunoexpression of
vascular markers is critical. The diagnosis should be in-
cluded in the differential diagnosis of epithelioid neo-
plasms of the bone, particularly for small specimens.Consent
The patient and the families were informed that data
from the case would be submitted for publication, and
provided their consent accordingly.
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